{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:01:54Z","timestamp":1761919314919},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.cancergencyto.2010.01.001","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T04:37:57Z","timestamp":1270096677000},"page":"162-165","source":"Crossref","is-referenced-by-count":2,"title":["JAK2 V617F-positive essential thrombocythemia in a patient with Klinefelter syndrome: a case report"],"prefix":"10.1016","volume":"198","author":[{"given":"Ho-Young","family":"Yhim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Youn","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Ju","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na-Ri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Kee","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam-Im","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Yeol","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Yong","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.01.001_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/jc.2002-021491","article-title":"Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study","volume":"88","author":"Bojesen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/dji240","article-title":"Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study","volume":"97","author":"Swerdlow","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00277-002-0430-2","article-title":"Agnogenic myeloid metaplasia associated with Klinefelter syndrome: a case report","volume":"81","author":"Kumar","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1749-6632.1970.tb39373.x","article-title":"Neoplasia and Down's syndrome","volume":"171","author":"Miller","year":"1970","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(08)70033-0","article-title":"Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study","volume":"9","author":"Schoemaker","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/bjc.1995.85","article-title":"Cancer incidence in men with Klinefelter syndrome","volume":"71","author":"Hasle","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/1097-0142(19870901)60:5<1053::AID-CNCR2820600520>3.0.CO;2-1","article-title":"Klinefelter's syndrome and extragonadal germ cell tumors","volume":"60","author":"Lee","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/(SICI)1097-0223(199704)17:4<363::AID-PD79>3.0.CO;2-O","article-title":"47,XXY (Klinefelter syndrome) and 47,XYY: estimated rates of and indication for postnatal diagnosis with implications for prenatal counselling","volume":"17","author":"Abramsky","year":"1997","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2005-11-009605","article-title":"Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders","volume":"108","author":"Kralovics","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib14","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/leu.2008.233","article-title":"Genetic complexity of myeloproliferative neoplasms","volume":"22","author":"Kralovics","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib15","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2005-12-013748","article-title":"Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation","volume":"108","author":"Campbell","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature03440","article-title":"The DNA sequence of the human X chromosome","volume":"434","author":"Ross","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-4608(02)00764-1","article-title":"Translocation (X;20)(q13.1;q13.3) as a primary chromosomal finding in two patients with myelocytic disorders","volume":"141","author":"Gray","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib18","first-page":"1100","article-title":"An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivation","volume":"91","author":"Vassiliou","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2010.01.001_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4161\/cc.4.2.1419","article-title":"Aneuploidy-cancer predisposition syndromes: a new link between the mitotic spindle checkpoint and cancer","volume":"4","author":"Hanks","year":"2005","journal-title":"Cell Cycle"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T23:56:33Z","timestamp":1544572593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0165460810000026"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.01.001","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}